Zille et al. found that class I histone deacetylase (HDAC) inhibitors selectively protect neurons but augment ferroptosis in cancer cells, which indicates that class I HDAC inhibitors are ideal drugs that not only exert anticancer effect but also protect normal cells [98]. The gene discussed is HDAC9; the disease is cancer.